Nyxoah Appoints Scott Holstine as Chief Commercial Officer
Nyxoah Appoints Scott Holstine as Chief Commercial Officer Mont-Saint-Guibert, Belgium – July 15, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a
BASF Environmental Catalyst and Metal Solutions breaks ground on new green hydrogen investment in Budenheim, Germany
Groundbreaking of new green hydrogen production facility in Budenheim, Germany Pictured left to right: Dr. Günter Krummel, Gesellschafter Trigona FCC; André Semann, CFO Budenheim; Meaghan McGuire, Head of Strategic Marketing,
Bombardier Announces Unifor Local 112 and 673 Employees Renew 3-Year Collective Agreement
MONTRÉAL, July 10, 2024 (GLOBE NEWSWIRE) — Bombardier announced today that Unifor’s Locals 112 and 673 members, working at the company’s Aircraft Assembly Centre in the Greater Toronto area, have
Bombardier Positions Challenger 3500 Business Jet Mockup in Olbia, Italy, For Customer Viewings Throughout the Summer
The Bombardier Challenger 3500 aircraft mockup The Bombardier Challenger 3500 business jet mockup is presented at the Costa Smeralda Airport in Olbia, Italy, after stops in Paris and Nice Full-size
2024 چین گوانسیان سٹیل پلیٹ انڈسٹری اوپننگ اپ اور بین الاقوامی پریسیشن پروکیورمنٹ کانفرنس گوانگچوئر کاؤنٹی،شانڈونگ صوبے میں منعقد ہوئی
گوانسیان، چین، 4 جولائی 2024ئ/سنہوا-ایشیانیٹ/– “عالمی تجارت کے لئے شانڈونگ اچھی مصنوعات” کے موضوع کے تحت 2024 چین گوانسیان سٹیل پلیٹ انڈسٹری اوپننگ اپ اور بین الاقوامی پریسیشن پروکیورمنٹ کانفرنس
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene